John Foringer, MD
Nephrology · Houston, TXNPI 1053339564
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $170,373 of the $214,823 with a category attached, or 79.3%. Otsuka America Pharmaceutical, Inc. accounts for 99.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $116,933 and has fallen 91.2% since, to $10,263 in 2025. Among nephrology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $798.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$214K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$847
- Sanofi$262
- Novartis$161
- AbbVie$21
- Johnson & Johnson$17
- plus $14 from 1 others
Across 1 payment — averaging $9979.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$10K
What the payments were for
- Consulting fees$13,1536%
- Speaking & faculty fees$170,37379%
- Travel & lodging$26,21212%
- Food & beverage$5,0002%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 255 | $213,502 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $847 |
| Sanofi | 1 | $262 |
| Novartis | 6 | $161 |
| AbbVie | 1 | $21 |
| Johnson & Johnson | 1 | $17 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$214,823 in reported general payments places this provider in the 95th percentile of 1,070 nephrology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Houston
- Sreedhar MandayamHouston$752K
- Christopher KwohHouston$467K
- Wolfgang WinkelmayerHouston$462K
- Namrata GoelHouston$426K
- Dana MitchellHouston$344K
- Ramachandra MalyaHouston$312K
- Biruh WorkenehHouston$185K
- Horacio AdrogueHouston$122K
- Anand SaranathanHouston$109K
- Kevin EricksonHouston$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.